CLINICAL & PIPELINE·Phase 3 Completion
GLP-1 Weight Loss Drugs Linked to Significant Decline in Physical Activity, Raising Muscle Health Concerns
A new study reveals GLP-1 weight loss drugs like Ozempic and Mounjaro lead to reduced physical activity, with daily steps falling from 5,047 to 4,487. This finding, presented at ENDO 2026, necessitates a re-evaluation of patient support and adjunctive therapies to mitigate muscle mass loss, creating new commercial opportunities for integrated health solutions.
90-Day Activity
PeopleHSN 3004.90
LVLakshmi Venkataraman· Senior Intelligence Analyst3d ago Phase 3 Completion